Pharma Lands One-Two Punch on Government Finances
Pharma lands one-two punch on government finances
Filed under: drug abuse treatment cost analysis program
In the GSK settlement, for example, the company allegedly participated in preparing, publishing and promoting a journal article that misleadingly asserted its drug Paxil was effective in treating depression in minors. … The ruling increases the …
Read more on Reuters Blogs (blog)
New study supports 15-day fill program for oral cancer medications and again …
Filed under: drug abuse treatment cost analysis program
Researchers analyzed the impact of cost, adherence rates and amount of prescription wasted among patients prescribed the oncology medication erlotinib (Tarceva®). The study showed less than two-thirds of patients taking erlotinib, a once-daily oral …
Read more on Sacramento Bee
Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin …
Filed under: drug abuse treatment cost analysis program
Because the tumor cells lack these certain receptors, neither hormone therapy nor drugs that target HER2 are effective treatments (but chemotherapy can still be useful if needed). … technological developments, costs of developing, producing and …
Read more on Sacramento Bee
New CF drug a paradigm shift in treating disease; but high cost "an issue"
Filed under: drug abuse treatment cost analysis program
The Common Drug Review does cost-benefit analyses for all provincial drug formularies, except that of Quebec. Kalydeco is only a treatment option for between three or four per cent of the roughly 4,000 Canadians who have cystic fibrosis. That's because …
Read more on Windsor Star